6 Followers on Owler
OverviewCompetitorsAcquisitionsFundingNews & Insights

Vistagen Competitors or Alternatives

Vistagen's top competitors include Relmada Therapeutics, Axsome and Alkermes.

Unlock 11 more competitors →

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

  • FUNDING

    REVENUE

  • EMPLOYEES

    FUNDING

  • REVENUE

  • CEO RATING

  • EMPLOYEES

  • FUNDING

  • REVENUE

Vistagen's company profile

Shawn K. Singh

CEO

90/100
40
$303.8M
$ < 1M
  • $303.8M
    $ < 1M
  • 40
    $303.8M
  • $ < 1M
  • 90/100
  • 40
  • $303.8M
  • $ < 1M
View ProfileView
1
Vistagen's Competitor - Relmada Therapeutics logo

Sergio Traversa

CEO

82/100
10
$425.4M
$6.3M
  • $425.4M
    $6.3M
  • 10
    $425.4M
  • $6.3M
  • 82/100
  • 10
  • $425.4M
  • $6.3M
View ProfileView
2
Vistagen's Competitor - Axsome logo

Herriot Tabuteau

Chairman & CEO

89/100
380
$829.7M
$385.7M
  • $829.7M
    $385.7M
  • 380
    $829.7M
  • $385.7M
  • 89/100
  • 380
  • $829.7M
  • $385.7M
View ProfileView
3
Vistagen's Competitor - Alkermes logo

Richard Pops

Chairman & CEO

61/100
1,800
$250M
$1.6B
  • $250M
    $1.6B
  • 1,800
    $250M
  • $1.6B
  • 61/100
  • 1,800
  • $250M
  • $1.6B
View ProfileView
4
Vistagen's Competitor - Sage Therapeutics logo

Barry E. Greene

CEO

83/100
690
$843M
$41.2M
  • $843M
    $41.2M
  • 690
    $843M
  • $41.2M
  • 83/100
  • 690
  • $843M
  • $41.2M
View ProfileView
5
Vistagen's Competitor - Abbott logo

Robert B. Ford

Chairman & CEO

82/100
115,000
$6.9M
$42B
  • $6.9M
    $42B
  • 115,000
    $6.9M
  • $42B
  • 82/100
  • 115,000
  • $6.9M
  • $42B
View ProfileView
Vistagen's top 14 competitors are Relmada Therapeutics, Axsome, Alkermes, Allergan, Sage Therapeutics, Abbott, Aptinyx, AstraZeneca, Lilly, Glaxosmithkline, Intra-Cellular, Janssen Pharmaceuticals, Lundbeck and Neurocrine Biosciences. Together they have raised over 4.7B between their estimated 271.2K employees. Vistagen has 40 employees and is ranked 12th among it's top 10 competitors. The top 10 competitors average 19,376.

Vistagen VS Relmada Therapeutics

Relmada Therapeutics is perceived as one of Vistagen's biggest rivals. Relmada Therapeutics was founded in 2004 in Coral Gables, Florida. Relmada Therapeutics is in the Biotechnology field. Relmada Therapeutics generates $5.6M more revenue than Vistagen.

Vistagen VS Axsome

Axsome is Vistagen's #2 rival. Axsome is a Public company that was founded in 2012 in New York, New York. Axsome competes in the Biotechnology field. Compared to Vistagen, Axsome has 340 more employees.

Vistagen VS Alkermes

Alkermes is one of Vistagen's top competitors. Alkermes's headquarters is in Dublin, County Westmeath, and was founded in 1987. Like Vistagen, Alkermes also operates in the Biotechnology industry. Alkermes generates 222,837% of Vistagen's revenue.

Looking for similar companies to Vistagen?

Similar Companies

Pharmaceuticals companies in South San Francisco

See 50 companies 
Companies in South San Francisco with revenue in $100K-5.0M range

See 194 companies 
Pharmaceuticals & Biotechnology companies in South San Francisco

See 173 companies 
Biotechnology companies in South San Francisco

See 150 companies 
Pharmaceuticals companies in San Francisco Bay Area

See 512 companies 
Companies in South San Francisco with employees in 25-100 range

See 592 companies 
Biotechnology companies in San Francisco Bay Area

See 1,319 companies 
Pharmaceuticals companies in California

See 1,457 companies 
Pharmaceuticals & Biotechnology companies in San Francisco Bay Area

See 1,673 companies 

Advanced Search

PRO

Discover new companies using five search parameters, including sector, location, public/private company status, employee count, and annual revenue.

Discover new companies using five search parameters.

Trending News for Vistagen and Vistagen's Competitors

April 11, 2025FinanzNachrichten
LONDON (dpa-AFX) - AstraZeneca PLC (AZN.L) Friday announced that all resolutions at its Annual General Meeting were approved by shareholders, with over...
April 12, 2025centralcharts
Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti , LLC ("KSF"), announces that KSF has...
April 11, 2025StreetInsider
ATLANTA, April 11, 2025 /PRNewswire/ --Â On April 01, 2025, OrderlyMeds received a Cease-and-Desist letter from Eli Lilly regarding the compounding of ...
April 11, 2025Openpr
Phenobarbital Market is estimated to be valued at USD 1.74 Bn in 2025 and is expected to reach USD 2.45 Bn in 2032, exhibiting a compound annual growth...
April 11, 2025Pharamceutical Technology
The twice daily tablet represents a significant step forward for patients with advanced breast cancer....
April 11, 2025Pharmabiz
As Mounjaro (tirzepatide), the blockbuster diabetes and weight loss drug from Eli Lilly, enters the Indian market, serious concerns have been raised ov...
April 11, 2025Openpr
Neuroregeneration Therapy Market is estimated to be valued at USD 14.77 Bn in 2025 and is expected to reach USD 33.69 Bn in 2032, exhibiting a compound...

Frequently Asked Questions about Vistagen

  1. Who are Vistagen's top competitors?

    Vistagen's top 3 competitors are Relmada Therapeutics, Axsome, Alkermes.

  2. Who is similar to Vistagen?

    Relmada Therapeutics is the most similar to Vistagen. Axsome and Alkermes are also similar to Vistagen.

  1. Are Vistagen and Relmada Therapeutics competitors?

    Yes, Relmada Therapeutics is one of Vistagen’s top competitors.